SYNTHESIS OF THROMBIN INHIBITOR DUP-714

被引：64

作者：

WITYAK, J

EARL, RA

ABELMAN, MM

BETHEL, YB

FISHER, BN

KAUFFMAN, GS

KETTNER, CA

MA, P

MCMILLAN, JL

MERSINGER, LJ

PESTI, J

PIERCE, ME

RANKIN, FW

CHORVAT, RJ

CONFALONE, PN

机构：

[1] The Du Pont Merck Pharmaceutical Company, Wilmington, Delaware 19880-0402

来源：

JOURNAL OF ORGANIC CHEMISTRY | 1995年 / 60卷 / 12期

关键词：

D O I：

10.1021/jo00117a024

中图分类号：

O62 [有机化学];

学科分类号：

070303 ; 081704 ;

摘要：

The asymmetric synthesis of thrombin inhibitor DuP 714 (1) is described. The route uses the Matteson boronic ester homologation to prepare the key intermediate, alpha-aminoboronic acid 4. New methodology was developed for the formamidination of boroornithine peptides and for pinanediol boronate ester cleavage.

引用

页码：3717 / 3722

页数：6

共 28 条

[1]

Kettner C., Mersinger L., Knabb R., J. Biol. Chem., 265, (1990)

[2]

Baldwin J.E., Claridge D.W., Derome A.E., Schofield C.J., Smith B.D., Bioorg. Med. Chem. Lett., 1, (1991)

[3]

Farr-Jones S., Smith S.O., Kettner C.A., Griffin R.G., Bachovchin W.W., Proc. Natl. Acad. Sci. U. S. A., 86, (1989)

[4]

Bone R., Frank D., Kettner C.A., Agard D.A., Biochemistry, 28, (1989)

[5]

Takahashi L.H., Radhakrishnan R., Rosenfield R.E., Meyer E.F., Biochemistry, 28, (1989)

[6]

Bachovchin W.W., Wong W.Y.L., Farr-Jones S., Shenvi A.B., Kettner C.A., Biochemistry, 27, (1988)

[7]

Bone R., Shenvi A.B., Kettner C.A., Agard D.A., Biochemistry, 26, (1987)

[8]

Matteson D.S., Jesthi P.K., Sadhu K.M., Organometallics, 3, (1984)

[9]

Matteson D.S., Tetrahedron, 45, (1989)

[10]

Matteson D.S., Chem. Rev., 89, (1989)

← 1 2 3 →